Global Intravenous (IV) Solution Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Intravenous (IV) Solution estimated at US$ 8062.9 million in the year 2022, is projected to reach a revised size of US$ 10420 million by 2028, growing at a CAGR of 4.4% during the forecast period 2022-2028.

Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Intravenous (IV) Solution manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Intravenous (IV) Solution market. Further, it explains the major drivers and regional dynamics of the global Intravenous (IV) Solution market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

ICU Medical

B. Braun Melsungen

Fresenius Kabi

Baxter

Amanta Healthcare

Terumo Medical

Grifols

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Total Parenteral Solution

Peripheral Parenteral Solution

Hospitals & Clinics

Ambulatory

Homecare

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Intravenous (IV) Solution market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Intravenous (IV) Solution, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Intravenous (IV) Solution, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intravenous (IV) Solution, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous (IV) Solution sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Intravenous (IV) Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Intravenous (IV) Solution sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including ICU Medical, B. Braun Melsungen, Fresenius Kabi, Baxter, Amanta Healthcare, Terumo Medical and Grifols, etc.

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Intravenous (IV) Solution Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Total Parenteral Solution

1.2.3 Peripheral Parenteral Solution

1.3 Market Segment by Application

1.3.1 Global Intravenous (IV) Solution Market Share by Application (2017 VS 2021 VS 2028)

1.3.2 Hospitals & Clinics

1.3.3 Ambulatory

1.3.4 Homecare

1.4 Study Objectives

1.5 Years Considered

2.1 Global Intravenous (IV) Solution Market Size (2017-2028)

2.1.1 Global Intravenous (IV) Solution Revenue (2017-2028)

2.1.2 Global Intravenous (IV) Solution Sales (2017-2028)

2.2 Global Intravenous (IV) Solution Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.2.1 Global Intravenous (IV) Solution Sales by Regions (2017-2022)

2.2.2 Global Intravenous (IV) Solution Revenue by Regions (2017-2022)

2.3 Global Intravenous (IV) Solution Market Size Forecast by Region

2.3.1 Global Intravenous (IV) Solution Sales Forecast by Region (2023-2028)

2.3.2 Global Intravenous (IV) Solution Revenue Forecast by Region (2023-2028)

2.4 Global Top Intravenous (IV) Solution Regions (Countries) Ranking by Market Size

2.5 Intravenous (IV) Solution Market Dynamics

2.5.1 Intravenous (IV) Solution Market Trends

2.5.2 Intravenous (IV) Solution Market Drivers

2.5.3 Intravenous (IV) Solution Market Challenges

2.5.4 Intravenous (IV) Solution Market Restraints

3.1 Global Top Intravenous (IV) Solution Manufacturers by Sales (2017-2022)

3.1.1 Global Intravenous (IV) Solution Sales by Manufacturers (2017-2022)

3.1.2 Global Intravenous (IV) Solution Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global 5 and 10 Largest Manufacturers by Intravenous (IV) Solution Sales in 2021

3.2 Global Top Manufacturers Intravenous (IV) Solution by Revenue

3.2.1 Global Intravenous (IV) Solution Revenue by Manufacturers (2017-2022)

3.2.2 Top Intravenous (IV) Solution Manufacturers Covered: Ranking by Revenue

3.2.3 Global Intravenous (IV) Solution Revenue Share by Manufacturers (2017-2022)

3.2.4 Global Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Solution as of 2021)

3.4 Global Intravenous (IV) Solution Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Intravenous (IV) Solution Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Intravenous (IV) Solution Market

3.7 Key Manufacturers Intravenous (IV) Solution Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Intravenous (IV) Solution Historic Market Review by Type (2017-2022)

4.1.1 Global Intravenous (IV) Solution Sales Market Share by Type (2017-2022)

4.1.2 Global Intravenous (IV) Solution Revenue Market Share by Type (2017-2022)

4.1.3 Intravenous (IV) Solution Price by Type (2017-2022)

4.2 Global Intravenous (IV) Solution Market Estimates and Forecasts by Type (2023-2028)

4.2.1 Global Intravenous (IV) Solution Sales Forecast by Type (2023-2028)

4.2.2 Global Intravenous (IV) Solution Revenue Forecast by Type (2023-2028)

4.2.3 Intravenous (IV) Solution Price Forecast by Type (2023-2028)

5.1 Global Intravenous (IV) Solution Historic Market Review by Application (2017-2022)

5.1.1 Global Intravenous (IV) Solution Sales Market Share by Application (2017-2022)

5.1.2 Global Intravenous (IV) Solution Revenue Market Share by Application (2017-2022)

5.1.3 Intravenous (IV) Solution Price by Application (2017-2022)

5.2 Global Intravenous (IV) Solution Market Estimates and Forecasts by Application (2023-2028)

5.2.1 Global Intravenous (IV) Solution Sales Forecast by Application (2023-2028)

5.2.2 Global Intravenous (IV) Solution Revenue Forecast by Application (2023-2028)

5.2.3 Intravenous (IV) Solution Price Forecast by Application (2023-2028)

6.1 North America Intravenous (IV) Solution Sales Breakdown by Company

6.1.1 North America Intravenous (IV) Solution Sales by Company (2017-2022)

6.1.2 North America Intravenous (IV) Solution Revenue by Company (2017-2022)

6.2 North America Intravenous (IV) Solution Market Size by Type

6.2.1 North America Intravenous (IV) Solution Sales by Type (2017-2028)

6.2.2 North America Intravenous (IV) Solution Revenue by Type (2017-2028)

6.3 North America Intravenous (IV) Solution Market Size by Application

6.3.1 North America Intravenous (IV) Solution Sales by Application (2017-2028)

6.3.2 North America Intravenous (IV) Solution Revenue by Application (2017-2028)

6.4 North America Intravenous (IV) Solution Market Size by Country

6.4.1 North America Intravenous (IV) Solution Sales by Country (2017-2028)

6.4.2 North America Intravenous (IV) Solution Revenue by Country (2017-2028)

6.4.3 U.S.

6.4.4 Canada

7.1 Europe Intravenous (IV) Solution Sales Breakdown by Company

7.1.1 Europe Intravenous (IV) Solution Sales by Company (2017-2022)

7.1.2 Europe Intravenous (IV) Solution Revenue by Company (2017-2022)

7.2 Europe Intravenous (IV) Solution Market Size by Type

7.2.1 Europe Intravenous (IV) Solution Sales by Type (2017-2028)

7.2.2 Europe Intravenous (IV) Solution Revenue by Type (2017-2028)

7.3 Europe Intravenous (IV) Solution Market Size by Application

7.3.1 Europe Intravenous (IV) Solution Sales by Application (2017-2028)

7.3.2 Europe Intravenous (IV) Solution Revenue by Application (2017-2028)

7.4 Europe Intravenous (IV) Solution Market Size by Country

7.4.1 Europe Intravenous (IV) Solution Sales by Country (2017-2028)

7.4.2 Europe Intravenous (IV) Solution Revenue by Country (2017-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8.1 Asia Pacific Intravenous (IV) Solution Sales Breakdown by Company

8.1.1 Asia Pacific Intravenous (IV) Solution Sales by Company (2017-2022)

8.1.2 Asia Pacific Intravenous (IV) Solution Revenue by Company (2017-2022)

8.2 Asia Pacific Intravenous (IV) Solution Market Size by Type

8.2.1 Asia Pacific Intravenous (IV) Solution Sales by Type (2017-2028)

8.2.2 Asia Pacific Intravenous (IV) Solution Revenue by Type (2017-2028)

8.3 Asia Pacific Intravenous (IV) Solution Market Size by Application

8.3.1 Asia Pacific Intravenous (IV) Solution Sales by Application (2017-2028)

8.3.2 Asia Pacific Intravenous (IV) Solution Revenue by Application (2017-2028)

8.4 Asia Pacific Intravenous (IV) Solution Market Size by Region

8.4.1 Asia Pacific Intravenous (IV) Solution Sales by Region

8.4.2 Asia Pacific Intravenous (IV) Solution Revenue by Region

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9.1 Latin America Intravenous (IV) Solution Sales Breakdown by Company

9.1.1 Latin America Intravenous (IV) Solution Sales by Company (2017-2022)

9.1.2 Latin America Intravenous (IV) Solution Revenue by Company (2017-2022)

9.2 Latin America Intravenous (IV) Solution Market Size by Type

9.2.1 Latin America Intravenous (IV) Solution Sales by Type (2017-2028)

9.2.2 Latin America Intravenous (IV) Solution Revenue by Type (2017-2028)

9.3 Latin America Intravenous (IV) Solution Market Size by Application

9.3.1 Latin America Intravenous (IV) Solution Sales by Application (2017-2028)

9.3.2 Latin America Intravenous (IV) Solution Revenue by Application (2017-2028)

9.4 Latin America Intravenous (IV) Solution Market Size by Country

9.4.1 Latin America Intravenous (IV) Solution Sales by Country (2017-2028)

9.4.2 Latin America Intravenous (IV) Solution Revenue by Country (2017-2028)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10.1 Middle East and Africa Intravenous (IV) Solution Sales Breakdown by Company

10.1.1 Middle East and Africa Intravenous (IV) Solution Sales by Company (2017-2022)

10.1.2 Middle East and Africa Intravenous (IV) Solution Revenue by Company (2017-2022)

10.2 Middle East and Africa Intravenous (IV) Solution Market Size by Type

10.2.1 Middle East and Africa Intravenous (IV) Solution Sales by Type (2017-2028)

10.2.2 Middle East and Africa Intravenous (IV) Solution Revenue by Type (2017-2028)

10.3 Middle East and Africa Intravenous (IV) Solution Market Size by Application

10.3.1 Middle East and Africa Intravenous (IV) Solution Sales by Application (2017-2028)

10.3.2 Middle East and Africa Intravenous (IV) Solution Revenue by Application (2017-2028)

10.4 Middle East and Africa Intravenous (IV) Solution Market Size by Country

10.4.1 Middle East and Africa Intravenous (IV) Solution Sales by Country (2017-2028)

10.4.2 Middle East and Africa Intravenous (IV) Solution Revenue by Country (2017-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 U.A.E

11.1 ICU Medical

11.1.1 ICU Medical Corporation Information

11.1.2 ICU Medical Overview

11.1.3 ICU Medical Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.1.4 ICU Medical Intravenous (IV) Solution Products and Services

11.1.5 ICU Medical Intravenous (IV) Solution SWOT Analysis

11.1.6 ICU Medical Recent Developments

11.2 B. Braun Melsungen

11.2.1 B. Braun Melsungen Corporation Information

11.2.2 B. Braun Melsungen Overview

11.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.2.4 B. Braun Melsungen Intravenous (IV) Solution Products and Services

11.2.5 B. Braun Melsungen Intravenous (IV) Solution SWOT Analysis

11.2.6 B. Braun Melsungen Recent Developments

11.3 Fresenius Kabi

11.3.1 Fresenius Kabi Corporation Information

11.3.2 Fresenius Kabi Overview

11.3.3 Fresenius Kabi Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.3.4 Fresenius Kabi Intravenous (IV) Solution Products and Services

11.3.5 Fresenius Kabi Intravenous (IV) Solution SWOT Analysis

11.3.6 Fresenius Kabi Recent Developments

11.4 Baxter

11.4.1 Baxter Corporation Information

11.4.2 Baxter Overview

11.4.3 Baxter Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.4.4 Baxter Intravenous (IV) Solution Products and Services

11.4.5 Baxter Intravenous (IV) Solution SWOT Analysis

11.4.6 Baxter Recent Developments

11.5 Amanta Healthcare

11.5.1 Amanta Healthcare Corporation Information

11.5.2 Amanta Healthcare Overview

11.5.3 Amanta Healthcare Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.5.4 Amanta Healthcare Intravenous (IV) Solution Products and Services

11.5.5 Amanta Healthcare Intravenous (IV) Solution SWOT Analysis

11.5.6 Amanta Healthcare Recent Developments

11.6 Terumo Medical

11.6.1 Terumo Medical Corporation Information

11.6.2 Terumo Medical Overview

11.6.3 Terumo Medical Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.6.4 Terumo Medical Intravenous (IV) Solution Products and Services

11.6.5 Terumo Medical Intravenous (IV) Solution SWOT Analysis

11.6.6 Terumo Medical Recent Developments

11.7 Grifols

11.7.1 Grifols Corporation Information

11.7.2 Grifols Overview

11.7.3 Grifols Intravenous (IV) Solution Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.7.4 Grifols Intravenous (IV) Solution Products and Services

11.7.5 Grifols Intravenous (IV) Solution SWOT Analysis

11.7.6 Grifols Recent Developments

12.1 Intravenous (IV) Solution Value Chain Analysis

12.2 Intravenous (IV) Solution Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Intravenous (IV) Solution Production Mode & Process

12.4 Intravenous (IV) Solution Sales and Marketing

12.4.1 Intravenous (IV) Solution Sales Channels

12.4.2 Intravenous (IV) Solution Distributors

12.5 Intravenous (IV) Solution Customers

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

    Table 1. Global Intravenous (IV) Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

    Table 2. Major Manufacturers of Total Parenteral Solution

    Table 3. Major Manufacturers of Peripheral Parenteral Solution

    Table 4. Global Intravenous (IV) Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

    Table 5. Global Intravenous (IV) Solution Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

    Table 6. Global Intravenous (IV) Solution Sales by Region (2017-2022) & (K MT)

    Table 7. Global Intravenous (IV) Solution Sales Market Share by Region (2017-2022)

    Table 8. Global Intravenous (IV) Solution Revenue by Region (2017-2022) & (US$ Million)

    Table 9. Global Intravenous (IV) Solution Revenue Market Share by Region (2017-2022)

    Table 10. Global Intravenous (IV) Solution Sales Forecast by Region (2023-2028) & (K MT)

    Table 11. Global Intravenous (IV) Solution Sales Market Share Forecast by Region (2023-2028)

    Table 12. Global Intravenous (IV) Solution Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 13. Global Intravenous (IV) Solution Revenue Market Share Forecast by Region (2023-2028)

    Table 14. Top Intravenous (IV) Solution Regions (Countries) Ranking by Market Size (US$ Million) in 2021

    Table 15. Intravenous (IV) Solution Market Trends

    Table 16. Intravenous (IV) Solution Market Drivers

    Table 17. Intravenous (IV) Solution Market Challenges

    Table 18. Intravenous (IV) Solution Market Restraints

    Table 19. Global Intravenous (IV) Solution Sales by Manufacturers (2017-2022) & (K MT)

    Table 20. Global Intravenous (IV) Solution Sales Share by Manufacturers (2017-2022)

    Table 21. Global Intravenous (IV) Solution Revenue by Manufacturers (2017-2022) & (US$ Million)

    Table 22. Ranking of Global Top Intravenous (IV) Solution Manufacturers by Revenue (US$ Million) in 2021

    Table 23. Intravenous (IV) Solution Revenue Share by Manufacturers (2017-2022)

    Table 24. Global Intravenous (IV) Solution Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Solution as of 2021)

    Table 26. Key Manufacturers Intravenous (IV) Solution Average Selling Price (ASP) & (2017-2022) & (USD/MT)

    Table 27. Key Manufacturers Intravenous (IV) Solution Plants/Factories Distribution

    Table 28. Key Manufacturers Intravenous (IV) Solution Area Served

    Table 29. Date of Key Manufacturers Enter into Intravenous (IV) Solution Market

    Table 30. Key Manufacturers Intravenous (IV) Solution Product Type

    Table 31. Mergers & Acquisitions, Expansion Plans

    Table 32. Global Intravenous (IV) Solution Sales (K MT) by Type (2017-2022)

    Table 33. Global Intravenous (IV) Solution Sales Share by Type (2017-2022)

    Table 34. Global Intravenous (IV) Solution Revenue (US$ Million) Market Share by Type (2017-2022)

    Table 35. Global Intravenous (IV) Solution Price (K MT) by Type (2017-2022)

    Table 36. Global Intravenous (IV) Solution Sales (K MT) by Type (2023-2028)

    Table 37. Global Intravenous (IV) Solution Sales Share by Type (2023-2028)

    Table 38. Global Intravenous (IV) Solution Revenue (US$ Million) Market Share by Type (2023-2028)

    Table 39. Global Intravenous (IV) Solution Revenue Share by Type (2023-2028)

    Table 40. Global Intravenous (IV) Solution Price (K MT) by Type (2023-2028)

    Table 41. Global Intravenous (IV) Solution Sales (K MT) by Application (2017-2022)

    Table 42. Global Intravenous (IV) Solution Sales Share by Application (2017-2022)

    Table 43. Global Intravenous (IV) Solution Revenue (US$ Million) Market Share by Application (2017-2022)

    Table 44. Global Intravenous (IV) Solution Price (K MT) by Application (2017-2022)

    Table 45. Global Intravenous (IV) Solution Sales (K MT) by Application (2023-2028)

    Table 46. Global Intravenous (IV) Solution Sales Share by Application (2023-2028)

    Table 47. Global Intravenous (IV) Solution Revenue (US$ Million) Market Share by Application (2023-2028)

    Table 48. Global Intravenous (IV) Solution Revenue Share by Application (2023-2028)

    Table 49. Global Intravenous (IV) Solution Price (K MT) by Application (2023-2028)

    Table 50. North America Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)

    Table 51. North America Intravenous (IV) Solution Sales Market Share by Company (2017-2022)

    Table 52. North America Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)

    Table 53. North America Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)

    Table 54. North America Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)

    Table 55. North America Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)

    Table 56. North America Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)

    Table 57. North America Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)

    Table 58. North America Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)

    Table 59. North America Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)

    Table 60. North America Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)

    Table 61. North America Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)

    Table 62. North America Intravenous (IV) Solution Sales by Country (2017-2022) & (K MT)

    Table 63. North America Intravenous (IV) Solution Sales by Country (2023-2028) & (K MT)

    Table 64. North America Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)

    Table 65. North America Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)

    Table 66. Europe Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)

    Table 67. Europe Intravenous (IV) Solution Sales Market Share by Company (2017-2022)

    Table 68. Europe Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)

    Table 69. Europe Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)

    Table 70. Europe Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)

    Table 71. Europe Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)

    Table 72. Europe Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)

    Table 73. Europe Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)

    Table 74. Europe Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)

    Table 75. Europe Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)

    Table 76. Europe Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)

    Table 77. Europe Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)

    Table 78. Europe Intravenous (IV) Solution Sales by Country (2017-2022) & (K MT)

    Table 79. Europe Intravenous (IV) Solution Sales by Country (2023-2028) & (K MT)

    Table 80. Europe Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)

    Table 81. Europe Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)

    Table 82. Asia Pacific Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)

    Table 83. Asia Pacific Intravenous (IV) Solution Sales Market Share by Company (2017-2022)

    Table 84. Asia Pacific Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)

    Table 85. Asia Pacific Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)

    Table 86. Asia Pacific Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)

    Table 87. Asia Pacific Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)

    Table 88. Asia Pacific Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)

    Table 89. Asia Pacific Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)

    Table 90. Asia Pacific Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)

    Table 91. Asia Pacific Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)

    Table 92. Asia Pacific Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)

    Table 93. Asia Pacific Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)

    Table 94. Asia Pacific Intravenous (IV) Solution Sales by Region (2017-2022) & (K MT)

    Table 95. Asia Pacific Intravenous (IV) Solution Sales by Region (2023-2028) & (K MT)

    Table 96. Asia Pacific Intravenous (IV) Solution Revenue by Region (2017-2022) & (US$ Million)

    Table 97. Asia Pacific Intravenous (IV) Solution Revenue by Region (2023-2028) & (US$ Million)

    Table 98. Latin America Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)

    Table 99. Latin America Intravenous (IV) Solution Sales Market Share by Company (2017-2022)

    Table 100. Latin America Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)

    Table 101. Latin America Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)

    Table 102. Latin America Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)

    Table 103. Latin America Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)

    Table 104. Latin America Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)

    Table 105. Latin America Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)

    Table 106. Latin America Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)

    Table 107. Latin America Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)

    Table 108. Latin America Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)

    Table 109. Latin America Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)

    Table 110. Latin America Intravenous (IV) Solution Sales by Country (2017-2022) & (K MT)

    Table 111. Latin America Intravenous (IV) Solution Sales by Country (2023-2028) & (K MT)

    Table 112. Latin America Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)

    Table 113. Latin America Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)

    Table 114. Middle East and Africa Intravenous (IV) Solution Sales by Company (2017-2022) & (K MT)

    Table 115. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Company (2017-2022)

    Table 116. Middle East and Africa Intravenous (IV) Solution Revenue by Company (2017-2022) & (US$ Million)

    Table 117. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Company (2017-2022)

    Table 118. Middle East and Africa Intravenous (IV) Solution Sales by Type (2017-2022) & (K MT)

    Table 119. Middle East and Africa Intravenous (IV) Solution Sales by Type (2023-2028) & (K MT)

    Table 120. Middle East and Africa Intravenous (IV) Solution Revenue by Type (2017-2022) & (US$ Million)

    Table 121. Middle East and Africa Intravenous (IV) Solution Revenue by Type (2023-2028) & (US$ Million)

    Table 122. Middle East and Africa Intravenous (IV) Solution Sales by Application (2017-2022) & (K MT)

    Table 123. Middle East and Africa Intravenous (IV) Solution Sales by Application (2023-2028) & (K MT)

    Table 124. Middle East and Africa Intravenous (IV) Solution Revenue by Application (2017-2022) & (US$ Million)

    Table 125. Middle East and Africa Intravenous (IV) Solution Revenue by Application (2023-2028) & (US$ Million)

    Table 126. Middle East and Africa Intravenous (IV) Solution Sales by Country (2017-2022) & (K MT)

    Table 127. Middle East and Africa Intravenous (IV) Solution Sales by Country (2023-2028) & (K MT)

    Table 128. Middle East and Africa Intravenous (IV) Solution Revenue by Country (2017-2022) & (US$ Million)

    Table 129. Middle East and Africa Intravenous (IV) Solution Revenue by Country (2023-2028) & (US$ Million)

    Table 130. ICU Medical Corporation Information

    Table 131. ICU Medical Description and Overview

    Table 132. ICU Medical Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)

    Table 133. ICU Medical Intravenous (IV) Solution Product and Services

    Table 134. ICU Medical Intravenous (IV) Solution SWOT Analysis

    Table 135. ICU Medical Recent Developments

    Table 136. B. Braun Melsungen Corporation Information

    Table 137. B. Braun Melsungen Description and Overview

    Table 138. B. Braun Melsungen Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)

    Table 139. B. Braun Melsungen Intravenous (IV) Solution Product and Services

    Table 140. B. Braun Melsungen Intravenous (IV) Solution SWOT Analysis

    Table 141. B. Braun Melsungen Recent Developments

    Table 142. Fresenius Kabi Corporation Information

    Table 143. Fresenius Kabi Description and Overview

    Table 144. Fresenius Kabi Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)

    Table 145. Fresenius Kabi Intravenous (IV) Solution Product and Services

    Table 146. Fresenius Kabi Intravenous (IV) Solution SWOT Analysis

    Table 147. Fresenius Kabi Recent Developments

    Table 148. Baxter Corporation Information

    Table 149. Baxter Description and Overview

    Table 150. Baxter Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)

    Table 151. Baxter Intravenous (IV) Solution Product and Services

    Table 152. Baxter Intravenous (IV) Solution SWOT Analysis

    Table 153. Baxter Recent Developments

    Table 154. Amanta Healthcare Corporation Information

    Table 155. Amanta Healthcare Description and Overview

    Table 156. Amanta Healthcare Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)

    Table 157. Amanta Healthcare Intravenous (IV) Solution Product and Services

    Table 158. Amanta Healthcare Intravenous (IV) Solution SWOT Analysis

    Table 159. Amanta Healthcare Recent Developments

    Table 160. Terumo Medical Corporation Information

    Table 161. Terumo Medical Description and Overview

    Table 162. Terumo Medical Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)

    Table 163. Terumo Medical Intravenous (IV) Solution Product and Services

    Table 164. Terumo Medical Intravenous (IV) Solution SWOT Analysis

    Table 165. Terumo Medical Recent Developments

    Table 166. Grifols Corporation Information

    Table 167. Grifols Description and Overview

    Table 168. Grifols Intravenous (IV) Solution Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2017-2022)

    Table 169. Grifols Intravenous (IV) Solution Product and Services

    Table 170. Grifols Intravenous (IV) Solution SWOT Analysis

    Table 171. Grifols Recent Developments

    Table 172. Key Raw Materials Lists

    Table 173. Raw Materials Key Suppliers Lists

    Table 174. Intravenous (IV) Solution Distributors List

    Table 175. Intravenous (IV) Solution Customers List

    Table 176. Research Programs/Design for This Report

    Table 177. Key Data Information from Secondary Sources

    Table 178. Key Data Information from Primary Sources

List of Figures

    Figure 1. Intravenous (IV) Solution Product Picture

    Figure 2. Global Intravenous (IV) Solution Sales Market Share by Type in 2021 & 2028

    Figure 3. Total Parenteral Solution Product Picture

    Figure 4. Peripheral Parenteral Solution Product Picture

    Figure 5. Global Intravenous (IV) Solution Sales Market Share by Application in 2021 & 2028

    Figure 6. Hospitals & Clinics Use Case

    Figure 7. Ambulatory Use Case

    Figure 8. Homecare Use Case

    Figure 9. Intravenous (IV) Solution Report Years Considered

    Figure 10. Global Intravenous (IV) Solution Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 11. Global Intravenous (IV) Solution Market Size 2017-2028 (US$ Million)

    Figure 12. Global Intravenous (IV) Solution Sales (2017-2022) & (K MT)

    Figure 13. Global Intravenous (IV) Solution Market Size Market Share by Region: 2021 VS 2028

    Figure 14. Global Intravenous (IV) Solution Sales Market Share by Region (2017-2022)

    Figure 15. Global Intravenous (IV) Solution Sales Market Share by Region in 2021

    Figure 16. Global Intravenous (IV) Solution Revenue Market Share by Region in 2017 VS 2021

    Figure 17. Global Intravenous (IV) Solution Sales Share by Manufacturers in 2021

    Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous (IV) Solution Sales in 2021

    Figure 19. Intravenous (IV) Solution Revenue Share by Manufacturers in 2021

    Figure 20. Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 21. Global Intravenous (IV) Solution Revenue Share by Type (2017-2022)

    Figure 22. Global Intravenous (IV) Solution Revenue Growth Rate by Type in 2017 & 2021

    Figure 23. Global Intravenous (IV) Solution Revenue Share by Application (2017-2022)

    Figure 24. Global Intravenous (IV) Solution Revenue Growth Rate by Application in 2017 & 2021

    Figure 25. North America Intravenous (IV) Solution Sales Market Share by Type (2017-2028)

    Figure 26. North America Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)

    Figure 27. North America Intravenous (IV) Solution Sales Market Share by Application (2017-2028)

    Figure 28. North America Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)

    Figure 29. North America Intravenous (IV) Solution Sales Share by Country (2017-2028)

    Figure 30. North America Intravenous (IV) Solution Revenue Share by Country (2017-2028)

    Figure 31. U.S. Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 32. Canada Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 33. Europe Intravenous (IV) Solution Sales Market Share by Type (2017-2028)

    Figure 34. Europe Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)

    Figure 35. Europe Intravenous (IV) Solution Sales Market Share by Application (2017-2028)

    Figure 36. Europe Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)

    Figure 37. Europe Intravenous (IV) Solution Sales Share by Country (2017-2028)

    Figure 38. Europe Intravenous (IV) Solution Revenue Share by Country (2017-2028)

    Figure 39. Germany Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 40. France Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 41. U.K. Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 42. Italy Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 43. Russia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 44. Asia Pacific Intravenous (IV) Solution Sales Market Share by Type (2017-2028)

    Figure 45. Asia Pacific Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)

    Figure 46. Asia Pacific Intravenous (IV) Solution Sales Market Share by Application (2017-2028)

    Figure 47. Asia Pacific Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)

    Figure 48. Asia Pacific Intravenous (IV) Solution Sales Share by Region (2017-2028)

    Figure 49. Asia Pacific Intravenous (IV) Solution Revenue Share by Region (2017-2028)

    Figure 50. China Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 51. Japan Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 52. South Korea Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 53. India Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 54. Australia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 55. Taiwan Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 56. Indonesia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 57. Thailand Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 58. Malaysia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 59. Philippines Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 60. Vietnam Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 61. Latin America Intravenous (IV) Solution Sales Market Share by Type (2017-2028)

    Figure 62. Latin America Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)

    Figure 63. Latin America Intravenous (IV) Solution Sales Market Share by Application (2017-2028)

    Figure 64. Latin America Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)

    Figure 65. Latin America Intravenous (IV) Solution Sales Share by Country (2017-2028)

    Figure 66. Latin America Intravenous (IV) Solution Revenue Share by Country (2017-2028)

    Figure 67. Mexico Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 68. Brazil Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 69. Argentina Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 70. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Type (2017-2028)

    Figure 71. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)

    Figure 72. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Application (2017-2028)

    Figure 73. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)

    Figure 74. Middle East and Africa Intravenous (IV) Solution Sales Share by Country (2017-2028)

    Figure 75. Middle East and Africa Intravenous (IV) Solution Revenue Share by Country (2017-2028)

    Figure 76. Turkey Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 77. Saudi Arabia Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 78. U.A.E Intravenous (IV) Solution Revenue (2017-2028) & (US$ Million)

    Figure 79. Intravenous (IV) Solution Value Chain

    Figure 80. Intravenous (IV) Solution Production Process

    Figure 81. Channels of Distribution

    Figure 82. Distributors Profiles

    Figure 83. Bottom-up and Top-down Approaches for This Report

    Figure 84. Data Triangulation

    Figure 85. Key Executives Interviewed